← United States · Coverage record
US · SEC FORM 4
Korro Bio, Inc.
KRRO · Nasdaq · CIK 0001703647 · Healthcare · Biotechnology
INSIDER SIGNAL
2 qualifying P purchase groups
in the current 180-day scoring window
40 Form 4 transaction lines observed in the same window
33 sales · 5 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-08-10 · Lynx1 Capital Management LP; Nichols Weston.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 1,675,219
- Previous report
- 1,551,984
- Avg daily volume
- 255,628
- Days to cover
- 6.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Lynx1 Capital Management LP; Nichols Weston | Purchase (P) | Common stock, $0.001 par value per share | 1,462 | USD 13.19 | USD 19,284 | SEC filing ↗ |
| 2026-08-06 | Lynx1 Capital Management LP; Nichols Weston | Purchase (P) | Common stock, $0.001 par value per share | 5,222 | USD 11.40 | USD 59,531 | SEC filing ↗ |
| 2026-03-10 | Yang Rick | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | Walker Paul Edward | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | SANDELL SCOTT D | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P. | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | Mathers Edward T | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | Makhzoumi Mohamad | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | Florence Anthony A. Jr. | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | Chang Carmen | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | BASKETT FOREST | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2024-04-22 | Yang Rick | Purchase (P) | Common Stock | 17,857 | USD 56.00 | USD 999,992 | SEC filing ↗ |
| 2024-04-22 | Walker Paul Edward | Purchase (P) | Common Stock | 17,857 | USD 56.00 | USD 999,992 | SEC filing ↗ |
| 2024-04-22 | SANDELL SCOTT D | Purchase (P) | Common Stock | 17,857 | USD 56.00 | USD 999,992 | SEC filing ↗ |
| 2024-04-22 | NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P. | Purchase (P) | Common Stock | 17,857 | USD 56.00 | USD 999,992 | SEC filing ↗ |
Form 4 evidence
55 transaction lines in the latest 365-day window; 392 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 38,490 | USD 14.12 | USD 543,479 | SEC filing ↗ |
| 2026-09-11 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 10,200 | USD 13.99 | USD 142,698 | SEC filing ↗ |
| 2026-09-11 | Dolan Oliver | Sale (S) | Common Stock | 5 | USD 13.72 | USD 69 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 38,490 | USD 14.12 | USD 543,479 | SEC filing ↗ |
| 2026-09-11 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 10,200 | USD 13.99 | USD 142,698 | SEC filing ↗ |
| 2026-09-11 | Dolan Oliver | Sale (S) | Common Stock | 5 | USD 13.72 | USD 69 | SEC filing ↗ |
| 2026-09-09 | Dolan Oliver | Sale (S) | Common Stock | 6 | USD 13.60 | USD 82 | SEC filing ↗ |
| 2026-09-08 | Dolan Oliver | Sale (S) | Common Stock | 7,347 | USD 13.51 | USD 99,258 | SEC filing ↗ |
| 2026-08-26 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 300 | USD 13.96 | USD 4,188 | SEC filing ↗ |
| 2026-08-19 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 28,468 | USD 14.00 | USD 398,552 | SEC filing ↗ |
| 2026-08-11 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 2,143 | USD 13.96 | USD 29,916 | SEC filing ↗ |
| 2026-08-10 | Lynx1 Capital Management LP; Nichols Weston | Purchase (P) | Common stock, $0.001 par value per share | 1,462 | USD 13.19 | USD 19,284 | SEC filing ↗ |
| 2026-08-06 | Lynx1 Capital Management LP; Nichols Weston | Purchase (P) | Common stock, $0.001 par value per share | 5,222 | USD 11.40 | USD 59,531 | SEC filing ↗ |
| 2026-08-04 | Aiyar Ram | Sale (S) | Common Stock | 5,802 | USD 10.84 | USD 62,894 | SEC filing ↗ |
| 2026-07-15 | Vincent Loic A | Award / grant (A) | Common Stock | 7,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-15 | Dolan Oliver | Award / grant (A) | Common Stock | 5,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-15 | Chappell Todd | Award / grant (A) | Common Stock | 7,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-15 | Cerio Jeffrey | Award / grant (A) | Common Stock | 6,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-06 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 9,323 | USD 13.96 | USD 130,149 | SEC filing ↗ |
| 2026-07-02 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 100,700 | USD 14.03 | USD 1,412,821 | SEC filing ↗ |
| 2026-06-24 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 48,438 | USD 14.61 | USD 707,491 | SEC filing ↗ |
| 2026-06-23 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 119,005 | USD 14.25 | USD 1,695,821 | SEC filing ↗ |
| 2026-06-22 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 3,962 | USD 13.95 | USD 55,270 | SEC filing ↗ |
| 2026-06-16 | Vincent Loic A | Sale (S) | Common Stock | 3,418 | USD 10.83 | USD 37,017 | SEC filing ↗ |
| 2026-06-16 | Dolan Oliver | Sale (S) | Common Stock | 3,383 | USD 10.83 | USD 36,638 | SEC filing ↗ |
| 2026-06-16 | Chappell Todd | Sale (S) | Common Stock | 3,168 | USD 10.83 | USD 34,309 | SEC filing ↗ |
| 2026-06-16 | Cerio Jeffrey | Sale (S) | Common Stock | 6,609 | USD 10.83 | USD 71,575 | SEC filing ↗ |
| 2026-05-29 | Aiyar Ram | Sale (S) | Common Stock | 15,152 | USD 12.98 | USD 196,673 | SEC filing ↗ |
| 2026-05-28 | FORMELA JEAN FRANCOIS | Sale (S) | Common Stock | 2,860 | USD 13.95 | USD 39,897 | SEC filing ↗ |
| 2026-05-26 | Aiyar Ram | Award / grant (A) | Common Stock | 50,000 | USD 12.33 | USD 616,500 | SEC filing ↗ |
| 2026-03-10 | Yang Rick | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | Walker Paul Edward | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
| 2026-03-10 | SANDELL SCOTT D | Purchase (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | KRRO |
| CIK | 0001703647 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 392 transaction lines from 2020-01-30 to 2026-09-14 23 P purchase lines · 283 S sale lines · 86 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.